Autism spectrum disorder (finished Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

How is ASD defined (diagnosed)?

A

Deficits in these 2 core domains (3 symptoms)

a) Atypical social behaviour

b) Disrupted verbal & non-verbal communication AND restrictive interests & repetitive behaviours

Onset before age 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is used in order to diagnose autism?

A

DSM- V = diagnostic and statistical manual of mental disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How often is a delay in spoken language seen in ASD cases?

A

Delay in spoken language seen in ~50% of cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What 3 previously separate diagnoses does the DSM-V combine into ASD?

A
  • ‘Autistic disorder’
  • ‘Asperger’s disorder’
  • ‘Pervasive developmental disorder - not otherwise specified (PDD-NOS)’
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What sort of therapy is available for patients w ASD?

A

Therapy restricted to behavioural intervention as so many different traits associated with ASD and the origin is hard to treat

Can benefit IF received early

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the FDA approved drugs for treating ASD and what does each one aim to do?

A

Antipsychotics:

  • Risperidone- treats aggressive and repetitive behaviour
  • Aripiprazole- reduces irritability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the 2 main treatments for ASD?

A
  • Behavioural intervention therapy
  • FDA approved drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the issue with using drugs to treat ASD?

A

Drugs don’t treat core social deficit just the behavioural symptoms managed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the prevalence of ASD in the early 1990s vs today?

A

Early 1990s = 1 in 1,000- diagnostics were not very developed

Today = est. 1 in 68 children under 8 in the USA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the prevalence of ASD in males vs females?

A
  • 1 in 42 for males
  • 1 in 189 in females

(5 fold for males)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the prevalent comorbidities of ASD?

A
  • Motor deficits
  • Sleep abnormalities
  • Gastrointestinal disturbances (50%) (gastrointestinal microbiome partly responsible for ASD)
  • Epilepsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What level of intelligence is generally found in children w ASD?

How about the 2 minorities of intelligence?

A

MOST ASD children have normal intelligence

35-50% have intellectual disability - defined as IQ <70

Small minority - have remarkable memory/intellect e.g. Einstein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the neuropathology of ASD?

A
  • No common macroscopic or microscopic neuropathology
  • Ne specific brain region or cell type implicated

(So cannot diagnose w brain imaging)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does head size differ in ASD?

A

~20% larger head size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Are there any biomarkers for ASD?

A

No biomarkers –> means no prediction at birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can an EEG be used for diagnosis?

A

Eye tracking movements (eye contact issues) & EEG can be helpful for diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the group of drugs that is used to treat ASD?

A

They are antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Name the 3 core autism symptoms

A
  • Social deficits
  • Language impairment
  • Repetitive behaviours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Name the 6 associated neurological issues in ASD?

A
  • Seizures
  • Sleep deficits
  • Mood
  • Anxiety
  • Hyperactivity
  • Attention (last 2 link to ADHD as a related disorder)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Name the 2 associated systemic issues in ASD

A
  • GI disorders
  • Immune dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are some of the typical early traits in ASD seen in children?

A
  • Inability to relate to children or adults
  • Poor speech or lack of speech
  • Inappropriate crying/laughter
  • Oversensitive or undersensitive to sound
  • Inappropriate playing w toys
  • Difficulty dealing w changes in routine
  • Oversensitive or undersensitive to touch
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What % of cases do genetic conditions contribute to ASD?

A

Rare genetic conditions contribute to 3% of ASD cases

Very small fraction of children w ASD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What % of children with an autistic sibling develop ASD?

A

20%

Certain degree of inheritance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is a De novo mutation?

A

A mutation that is present in the offspring but not inherited (absent) from either parent- occur after fertilisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How can a De novo mutation cause ASD?

How frequent are they?

A

Coding differences occurring after fertilisation (not inherited from either parent)

Occur in 5-10% of all cases

A sporadic form - not inherited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How often do genetic mutations cause ASD?

A

80-85% = no clear genetic cause

  • 3% mendelian single gene inherited
  • 5% chromosome anomalies & CNVs
  • 5-10% De novo single gene mutations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How can chromosome anomalies & CNVs cause ASD & how common are they?

A

5% of cases caused by copy number variations

Large sections of the genome replicated/deleted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Which gene has been found to be affected by de novo mutations in ASD?

A

The gene producing the protein TRIO

It is responsible for the early formation of dendritic spines of glutamatergic neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What % of children w an autistic sibling develop ASD?

A

20% = certain degree of inheritance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is the main factor that results in ASD?

A

predominantly due to difficulties in early development that is mainly neuronal networks which then in adulthood will be showing as behavioural abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the 3 levels at which ASD develops on?

A
  • Neuroanatomical
  • Systems-level
  • Cellular and molecular
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What are the neuroanatomical ways that ASD differs?

A
  • Brain growth- ASD have larger brains in early stages but throughout development this normalises
  • Cortical columns- neurons form these networks in very early stages but these are altered in ASD (malfunctions)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

How does brain growth differ in those w ASD?

A

Children w ASD tend to have larger brains

Thru development this normalises again in adolescence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

How do cortical columns differ in those w ASD?

A
  • There is disorder of neuronal connectivity esp in the cerebral cortex
  • Malfunctions occur in the formation of these early networks
35
Q

How does pathfinding differ in ASD both prenatal & postnatal?

A

Prenatal –> neuronal migration & axonal pathfinding is different

Postnatal –> dendritic development, synaptic pruning & neurogenesis differs- involved in forming networks in brain

36
Q

What are the systems-level ways that ASD differs?

A
  • White matter tracts & functional connectivity
  • Balance of excitations/inhibition
37
Q

How does the balance of excitations/inhibition lead to ASD?

A

Some genes cause different prenatal pathfinding

So more excitatory than inhibitory neurones forming

38
Q

What are the genes involved in systems-level ASD causes?

A
  • NRXN1
  • NLGN2&3
  • SHANK3 (excitatory) - has been shown to have particular links to ASD
39
Q

How many genes are involved in malfunction of circuits in ASD?

A

> 100 susceptible genes covering on pathways involving synaptic transmission

(Different genes may contribute to the 3 distinct symptoms)

40
Q

What are the cellular & molecular ways that ASD differs?

A
  • Activity-dependent protein synthesis
  • Neuronal activity
  • Neuronal cell adhesion
41
Q

What are the genes found at a cellular & molecular level that contribute to ASD & what do each of them do?

A
  • SCN2A &1A - related to VGSCs
  • GRIN2A & B - NMDA receptors
  • GRIK2 - kinase receptors
  • CACNA1C & H - VGCCs

(Genes encoding for these proteins shown to be associated w ASD)

42
Q

What does the biological convergence of genes & pathways affect?

A
  • Synapse formation
  • Neuronal activity
  • Neuronal cell adhesion
43
Q

What 6 areas of genes are affected in ASD?

A
  • Synaptogenesis
  • Protein synthesis
  • Chromatin remodelling & transcription
  • Protein degredation
  • Phospholipid homeostasis
  • Cytoskeleton dynamics
44
Q

What is synaptogenesis?

A

= formation of synapses between neurons

45
Q

What are the genes that are affected in synaptogenesis in ASD?

A
  • Neurolexin
  • Neuroligin
  • Neurobeachin
  • DAT
  • mGluR
  • Neulexin IV
  • Synaptojanin
46
Q

What is the gene in ASD that affects both cytoskeleton dynamics & synaptogenesis?

A

SHANK gene

47
Q

What is the main function of neuroligin and neurexin?

A

= cell adhesion proteins responsible for forming appropriate synaptic connections

48
Q

What are neuroligins + their function?

A

= synaptic cell-adhesion molecules at postsynaptic neuronal membranes and interact with either glutamate (NMDA receptors – excitatory) or GABA receptors (– inhibitory) to the synapse and maintain the excitatory/inhibitory balance

49
Q

What is a neurexin?

A

= components of the presynaptic neuronal membrane and their intracellular domain interacts with proteins involved in exocytosis- to allow synaptic vesicle recyling

50
Q

Explain how immunostaining was used to see the effect of neuroligin + results

A

Effect neuroligin by introducing a mutation (R451C) will alter GABAergic activity
Can look at via immunostaining- stain for VGAT in the presynaptic vesicles
- mutate protein = increased signal of GABA presynaptic neuron (more green dots)
= neuroligin is responsible for expression of GABAergic neurons

51
Q

Explain how electrophysiological data was used to see the effect of neuroligin + results

A

Can study functional effects of same mutation
can measure spontaneous activities of neurons:
- EPCs = excitatory postsynaptic currents mediated by glutamate
- IPCs = inhibitory postsynaptic currents mediated by GABA

Increased activity of GABAergic activity following mutation = more GABA activity as neuroligin affected = direct link

52
Q

Explain how behavioural was used to see the effect of neuroligin + results

A

Measure social interactions in mice via time spent with a partner
But mutants spent less time interacting with their partners

53
Q

What other protein is important in ASD?

A

dopamine receptors

54
Q

Describe an experiment that suggests D2 receptors are involved in ASD

A

Human brain samples have been used for experiments with a radio-label (mRNA)
ASD vs controls = Dopamine receptor 1 is unaltered but DR2 in ASD have higher levels of these receptors

55
Q

What do D2 receptors lead to and where are they found?

A

= pre and post synaptic neurons- high levels in striatum
lead to reduction in cAMP signalling

56
Q

What is another protein associated with ASD?

A

DAT = dopamine transporter

57
Q

Describe an experiment that suggests DAT is involved in ASD

A

Mutation inserted into Human DAT protein (T356M)- showed DAT has impaired ability to transport dopamine (shown in graph)
No effect on expression (shown on bar graph)

58
Q

What is this multi sequence alignment showing?

A

threonine = preserved across different species- suggesting important function involving DAT

59
Q

What happens when there is a T356M mutation and where is it located?

A

Knock threonine amino acid = reduce activity of DAT as mutation is located on transmembrane domain 7

60
Q

Describe an experiment on drosophila that suggests DAT is involved in ASD

A

Drosophila- assess activity
Put flies into tube with infrared beam going through, which measures how many times fly crosses beam = readout of fly activity
Insert T356M into flies or knockout DAT = activity increases / hyperactive

61
Q

Outline the causes and risk factors of ASD

A
62
Q

Is age a risk factor for developing ASD + explain?

A

Yes- increased risk with increasing maternal age = age 25 to 40 the risk of developing ASD doubles
- same applies to male- if father is >10 years older than mother = increased risk

63
Q

What is another neurotransmitter that is implicated in ASD?

A

serotonin

64
Q

How is serotonin implicated in ASD?

A
  • hyperserotonemia
65
Q

What is hyperserotonemia and how many people with ASD does this occur in?

A

Elevated whole blood serotonin levels (particularly in platelets)- Elevated whole blood serotonin levels (particularly in platelets) occur in approximately 25% of children with autism

66
Q

What other disorders are associated with hyperserotenemia?

A

OCD

67
Q

What is hyperserotonemia caused by?

A

Increased 5-HT production by enterochromaffin cells in the intestine, increased uptake of 5-HT into the platelet, decreased metabolic breakdown of 5- HT

68
Q

Outline some evidence that suggests 5-HT is involved in ASD

A

Tryptophan depletion which decreases synaptic 5-HT, worsens repetitive behaviours and irritability in autism

69
Q

Outline some neuroimaging evidence that suggests 5-HT is involved in ASD

A

Neuroimaging studies found decreased 5-HT2A receptor binding in adults with Asperger’s syndrome and parents of children with autism

70
Q

What other 5-HT mechanisms have been shown to altered in ASD?

A

deactivation mechanisms- SERT and MAO-A

71
Q

What does the genetic knock out of SERT do?

A

Genetic knock-out of SERT alters brain development, including overall brain growth and interneuron migration into the cortex
- affected early on during development = impacts on path finding and synaptogenesis events

72
Q

Name a treatment involved in increasing serotonin levels in the brain and does it have any benefits for ASD?

A

SSRIs = have little therapeutic benefit on ASD

73
Q

Where are serotonergic neurons expressed?

A

expressed in dorsal and median raphe neurons

74
Q

What is gene encoding SERT and what chromosome is it located on?

A

Gene encoding serotonin transporter [member of’solute carrier family 6’(SLC6A4)] on chromosome 17 = mutation in this potentially leads to ASD

75
Q

How is the SLC6A4 gene altered in ASD?

A

Promotor region of the SLC6A4 gene contains a polymorphism leading to “short 14” and “long 16” repeats; the short 14 repeat reduces transcription and is associated with anxiety-related traits and altered brain structure.

76
Q

Describe how the most common SERT amino acid variant was examined in mice

A

SERT Gly56Ala knock-in mouse (=mutation reducing SERT activity) has elevated blood serotonin, altered serotonergic raphe neuron firing (reduced firing)
+ altered social behaviours- 3-chamber crawley sociability test:
= Put mice into 3 chambers
1. one chamber has mouse in glass
2. One chamber has no mouse in glass
3. Mouse placed into middle chamber and allowed to explore
= usual behaviour = mouse spends time investigating chamber with other mouse
Measure time mice spent investigating- compare times with wildtype and those with Gly56Ala mutation = mutant mice reduced time spent investigating other mouse

77
Q

How is the Gut brain axis involved in ASD?

A

Changes in the gut microbiota composition and resultant altered gut-derived microbial products and neurotransmission can over-activate the immune system producing increased oxidative stress and impact on serotonin signalling.

78
Q

Describe the basic structure of the gut-brain axis

A
  1. microbiome in gut produces many chemicals- some beneficial and some toxic
  2. Communcation via vagus nerve that signals from the gut to the brain
  3. communication via bloodstream from gut into brain

Gut biota can produce a huge range of chemicals including serotonin, inflammatory molecules etc - which signal into brain

Happens in both mammalian systems and drosophila

79
Q

Outline some gastro-intestinal disturbances associated with ASD

A

Whole range of gastro-intestinal disturbances in ASD- which specifically interact with the serotonergic pathways
- Certain bacteria able to intefere with cascade of serotonin synthesis e.g. clostridium

80
Q

Which neurotransmitters are effected (produced/interferred with) by the gut brain axis

A

Whole range of neurotransmitters
- Noradrenaline(Escherichiaspp (E coli),Bacillusspp.andSaccharomycesspp.)
- Dopamine (Bacillusspp.)
- Serotonin- (Candidaspp.,Streptococcusspp.,Escherichiaspp. (E coli) andEnterococcusspp.)
- GABA (Lactobacillusspp. andBifidobacteriumspp.)
- Acetylcholine(Lactobacillusspp.)

81
Q

How is the gut-brain axis implicated in ASD

A
  1. changes in microbiome
  2. = changes activity of endochromaffin cells- produce neuro-inflammatory molecules
  3. Via vagus nerve this is signalled to brain + also can be via bloodstream to brain where the BBB is crossed = cytokines are able to interfere with neuronal function
    = cascades responsible for dis-development of the brain- that has worse impacts if it occurs in early development
82
Q

Name some examples of bacteria that have been shown to be beneficial to neuronal development + what do they do?

A
  • Lactobacillus reuterihas the capacity to upregulate plasmaand brain levels of oxytocin (increases social behaviour in mouse models of ASD).
  • Lactobacillus rhamnosusproduces GABA and regulates GABA receptors in the brain.
  • Bifidobacterium longumupregulates brain-derived neurotrophic factor (BDNF), augments neuronal plasticity in the enteric nervous system (ENS) and reduces anxiety and depression-like behaviours in mice.
  • Bacteroides fragilisimproves anxiety-like behaviour, repetitive behaviour and communication in mice.
83
Q

Describe an experiment which shows the effect of bacteroides fragilis on ASD

A

Bacteroides fragilis used as a treatment can releive autism like behaviour abnormalities in mice:
1. Immune activation induced in mother during pregnancy = injected with inflammatory molecule, so offspring exposed to maternal immune activation
2. Then measured anxiety-like behaviours in off-spring- had open platform that is usually fully explored but if anxious they hide
3. Hiding behaviour was associated when off-spring exposed to maternal immune activation
4. But treatment with bacteroides fragilis = increase in exploratory behaviour despite still experiencing maternal immune activation = suggests early developmental abnormalities can be reversed by beneficial bacteria